Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AChE/BChE-IN-15 (Compound 6d) serves as an inhibitor for both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), presenting inhibition constants (IC50) of 20 nM for AChE and 220 nM for BChE. It interacts with the catalytic anionic site (CAS) and the peripheral anionic site (PAS) within the enzymes' active sites. AChE/BChE-IN-15 is applicable in Alzheimer’s disease research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | AChE/BChE-IN-15 (Compound 6d) serves as an inhibitor for both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), presenting inhibition constants (IC50) of 20 nM for AChE and 220 nM for BChE. It interacts with the catalytic anionic site (CAS) and the peripheral anionic site (PAS) within the enzymes' active sites. AChE/BChE-IN-15 is applicable in Alzheimer’s disease research [1]. |
Molecular Weight | 510.59 |
Formula | C29H30N6O3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AChE/BChE-IN-15 inhibitor inhibit